etoposide has been researched along with Cancer of Nasopharynx in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Allison, DL; Glaser, R; Holliday, JE; Kamat, PL; Liebowitz, SM; Moeschberger, ML; Schaller, JP; Witiak, DT | 1 |
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB | 1 |
| Asa, SL; Dorth, J; Mohamed, A; Prantesh, J | 1 |
| Hope, AJ; Papp, S; Perez-Ordóñez, B; Wasserman, JK | 1 |
| Mantle, B; Osborne, RF | 1 |
| Abdulrezzak, U; Cetin, M; Kaynar, L; Keklik, M; Kontas, O; Sivgin, S | 1 |
| Daoud, J; Elloumi, F; Fourati, N; Frikha, M; Ghorbel, A; Ghorbell, L; Jlidi, R; Siala, W | 1 |
| Jacobson, C; LaCasce, A | 1 |
| Haba, R; Hoshikawa, H; Miyashita, T; Shibata, T; Takahashi, S; Togami, T | 1 |
| Avitia, S; Hamilton, JS; Osborne, RF | 1 |
| Ernberg, IT; Fadeel, B; Hu, L; Zhang, X | 1 |
| Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
| Chen, LM; Ding, Y; Fu, LW; Liang, YJ; Pan, QC; Xiong, HY; Yang, XP | 1 |
| Ernberg, IT; Fadeel, B; Hu, L; Uthaisang, W; Zhang, X | 1 |
| Busson, P; Cillessen, SA; Dukers, DF; Harijadi, A; Hariwiyanto, B; Meijer, CJ; Middeldorp, J; Oudejans, JJ; Tan, IB; Vos, W | 1 |
| Cheng, WW; Cho, WC; Law, SC; Ma, VW; Ngan, RK; Podust, VN; Yip, C; Yip, TT; Yip, V; Yiu, HH | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Chien, CY; Huang, HY; Hwang, CF; Lin, IH | 1 |
| Barrows, LR; Haughey, HM; Holden, JA; Ireland, CM; Matsumoto, SS; Schmehl, DM; Venables, DA | 1 |
| Chen, LT; Huang, TS; Lee, CC; Shu, CH; Whang-Peng, J | 1 |
| Chao, Y; Chen, LT; Huang, TS; Shu, CH | 1 |
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
| Band, PR; Connors, JM; Fetherstonhaugh, EM; Goldie, JH; Knowling, MA; Osoba, D | 1 |
| Beattie, M; Kingston, JE; Malpas, JS; Norton, AJ | 1 |
| Daghistani, D; Davis, J; Toledano, S | 1 |
| Shiu, WC; Tsao, SY | 1 |
| Cheng, YC; Ferguson, PJ | 1 |
4 review(s) available for etoposide and Cancer of Nasopharynx
| Article | Year |
|---|---|
Nasopharyngeal neuroendocrine neoplasms: Systematic review of the literature and case presentation.
Topics: Adult; Anemia, Sickle Cell; Antineoplastic Agents; Black or African American; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Accelerated hyperfractionated radiotherapy for small cell carcinoma of the nasopharynx.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cisplatin; Dose Fractionation, Radiation; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Risk Assessment; Treatment Outcome | 2015 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
23 other study(ies) available for etoposide and Cancer of Nasopharynx
| Article | Year |
|---|---|
Bis(bioreductive) alkylating agents: synthesis and biological activity in a nude mouse human carcinoma model.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Burkitt Lymphoma; Cell Line; Cisplatin; Drug Resistance; Humans; Methotrexate; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Quinones; Tumor Stem Cell Assay; Vinblastine | 1983 |
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors | 2011 |
Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Epstein-Barr Virus Infections; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Tuberous Sclerosis | 2018 |
Nasopharyngeal yolk sac tumors: a rare pediatric occurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blindness; Child, Preschool; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Steroids; Tomography, X-Ray Computed | 2013 |
Langerhans cell sarcoma of the nasopharynx: a rare case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Humans; Langerhans Cell Sarcoma; Male; Nasopharyngeal Neoplasms; Prednisone | 2013 |
[Large cell neuroendocrine carcinoma of the nasopharynx: A case report].
Topics: Adult; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Nasal Obstruction; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tinnitus | 2014 |
How I treat Burkitt lymphoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Translocation, Genetic; Vincristine | 2014 |
Lymphoma in the Waldeyer ring: a great masquerader.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Endoscopy; Etoposide; Head and Neck Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Rituximab; Tonsillar Neoplasms; Treatment Outcome; Vincristine | 2009 |
Apoptosis modulation of Epstein-Barr virus-encoded latent membrane protein 1 in the epithelial cell line HeLa is stimulus-dependent.
Topics: Apoptosis; Caspase 3; Caspases; DNA-Binding Proteins; Etoposide; fas Receptor; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Nasopharyngeal Neoplasms; Nuclear Proteins; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor alpha-Induced Protein 3; Tumor Necrosis Factor-alpha; Viral Matrix Proteins | 2002 |
[Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Etoposide; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation.
Topics: Antineoplastic Agents; Apoptosis; Caspase 2; Caspases; Cisplatin; Cytochromes c; Enzyme Activation; Etoposide; HeLa Cells; Herpesvirus 4, Human; Humans; Membrane Potentials; Mitochondria; Nasopharyngeal Neoplasms; Protein Structure, Tertiary; Stress, Physiological; Transfection; Tumor Cells, Cultured; Viral Matrix Proteins | 2005 |
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biopsy; Caspase 3; Caspases; Cell Line, Tumor; Enzyme Activation; Etoposide; Female; Humans; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Neoplasms; Nasopharynx; Proteins; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Survival Rate; T-Lymphocytes, Cytotoxic; X-Linked Inhibitor of Apoptosis Protein | 2005 |
ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma.
Topics: Adult; Alpha-Globulins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Platelet Factor 4; Protein Array Analysis; Protein Precursors; Salvage Therapy | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Small cell carcinoma of the nasopharynx.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Fatal Outcome; Humans; Male; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant | 2007 |
Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Pyrroles; Quinolones; Topoisomerase II Inhibitors | 1999 |
In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Etoposide; Fluorouracil; Nasopharyngeal Neoplasms; Toxicity Tests; Tumor Cells, Cultured | 2000 |
Evaluation of GL331 in combination with paclitaxel: GL331's interference with paclitaxel-induced cell cycle perturbation and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Calcium-Binding Proteins; Carrier Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cyclin B; Cyclin B1; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Antagonism; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Etoposide; Flow Cytometry; Fungal Proteins; Humans; Nasopharyngeal Neoplasms; Nuclear Proteins; Paclitaxel; Precipitin Tests; Protein Kinases; Tetrazolium Salts; Thiazoles; Toxicity Tests; Tumor Cells, Cultured | 2001 |
Treatment of recurrent and metastatic head and neck cancer with cisplatin/etoposide/bleomycin.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Creatinine; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycins; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Survival Rate | 1992 |
Nasopharyngeal rhabdomyosarcoma presenting as a breast mass.
Topics: Adolescent; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Nasopharyngeal Neoplasms; Rhabdomyosarcoma; Tomography, X-Ray Computed; Vincristine | 1990 |
Case report of successful use of VP-16 in nasopharyngeal carcinoma.
Topics: Adolescent; Carcinoma; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Patient Compliance; Remission Induction | 1989 |
Etoposide (VP16-213) in the treatment of advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms | 1988 |
Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoylphorbol-13-acetate.
Topics: Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Diglycerides; Dose-Response Relationship, Drug; Etoposide; Humans; Methotrexate; Mitoxantrone; Nasopharyngeal Neoplasms; Tetradecanoylphorbol Acetate; Time Factors; Type C Phospholipases; Verapamil; Vincristine | 1987 |